Skip to content
sellNotable cluster of 2

Dss, Inc. sold $845k of IBO

owner at IMPACT BIOMEDICAL INC.. 890,800 shares at an average of $0.95, traded Apr 4, 2025, filed Apr 7, 2025.

Warning score
63
Value
$845k
890,800 shares
Holdings after
161,100
-85% from before
From 52-week low
+108%
low $5.87, close $12.19
From 52-week high
-81%
high $62.78, as of Apr 4, 2025

Score components

  • Role
    10% owner
    +12
  • Trade size
    $845k at market
    +23
  • Share of holdings sold
    Sold 85% of holdings
    +20
  • Cluster
    2 insiders selling within 14 days
    +8

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -41.2%, 3m -27.7%, 6m -26.6%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

IBOOct 12, 2026 · close 4.03
Since filing Apr 7, 2025: -63.3%SPY +56.8% · excess -120.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001641172-25-003114, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 4, 2025SOpen-market sale
Common Stock
-890,800$0.95$845k161,100Apr 7, 2025

Related signals

Other insiders at IMPACT BIOMEDICAL INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
12Weak
IBOsell
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$1,686
906 shares
-0%
40Moderate
IBOsell 2
IMPACT BIOMEDICAL INC.
Todd D Macko
Chief Financial Officer
$25k
45,000 shares
-23%
34Weak
IBOsell 2
IMPACT BIOMEDICAL INC.
Jason Grady
director
$33k
50,000 shares
-17%
26Weak
IBOsell
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$88k
161,000 shares
-23%
41Moderate
IBOsell
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$88k
161,000 shares
-100%
54Moderate
IBOsell 2
IMPACT BIOMEDICAL INC.
Heng Fai Ambrose Chan
director
$174k
351,555 shares
-100%
68Notable
IBOsell 2
IMPACT BIOMEDICAL INC.
Heng Fai Ambrose Chan
director, owner
$1.1M
1,689,693 shares
-198%
68Notable
IBOsell 2
IMPACT BIOMEDICAL INC.
Heng Fai Ambrose Chan
director, owner
$2.9M
2,526,918 shares
-163%
65Notable
IBOsell 2
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$2.0M
605,620 shares
-364%
2Weak
IBObuy
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$310
200 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Dss, Inc. sold $845k of IBO | InsiderTell